SAVIENT PHARMACEUTICALS INC
DelistedCIK 722104fmd_02X9XNRA5SRW1E9AHRJMHP15J8Manufacturing · Medicinal Chemicals & Botanical ProductsTemplate: Standard
Coverage: Jan 01, 2008 to Sep 30, 2013, 19 periods
| Line item | FY2008 | FY2009 | FY2010 | FY2011 | FY2012 |
|---|---|---|---|---|---|
| Total revenues | 3 | 3 | 4 | 10 | 18 |
| Cost of revenue | 1 | 2 | 3 | 9 | 22 |
| Gross profit | 2 | 1 | 1 | 0 | (4) |
| Realized investment gains (losses) | – | 1 | – | – | – |
| Research and development | 55 | 52 | 32 | 25 | 26 |
| Selling, general and administrative | 36 | 31 | 25 | 91 | 89 |
| Total operating expenses | 92 | 84 | 60 | 125 | 137 |
| Operating income | (89) | (81) | (56) | (115) | (119) |
| Interest expense | – | – | – | 16 | 24 |
| Interest and investment income | – | 0 | 0 | 0 | – |
| Other non-operating income (expense) | (0) | (0) | (0) | 0 | 0 |
| Income before taxes | (88) | (93) | (73) | (129) | (118) |
| Income tax expense | (5) | (2) | (0) | (27) | – |
| Net income from continuing operations | (83) | (91) | (73) | (102) | – |
| Net income | (84) | (91) | (73) | (102) | (118) |
| Net income to common shareholders | – | (91) | (73) | (102) | – |